_id
69185e8a3c536f8df2317d9e
Ticker
0R1F.LSE
Name
Bristol Myers Squibb Co.
Exchange
LSE
Address
Route 206 & Province Line Road, Princeton, NJ, United States, 08543
Country
UK
Sector
Industry
Currency
USD
Website
https://www.bms.com
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Last Close
72.7
Volume
74379
Current Price
52.7293
Change
0
Last Updated
2025-12-05T15:06:46.833Z
Image
https://logo.clearbit.com/www.bms.com
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-03-31
Revenue
11865000000
Cost Of Revenue
2910000000
Gross Profit
8955000000
Operating Expenses
20226000000
Operating Income
2284000000
Interest Expense
-
Pretax Income
-11516000000
Net Income
-11911000000
Eps
-5.8877904102817595
Dividends Per Share
1212000000
Shares Outstanding
1632199936
Income Tax Expense
392000000
EBITDA
4754000000
Operating Margin
19.249894648124737
Total Other Income Expense Net
-13800000000
Cash
9330000000
Short Term Investments
340000000
Receivables
10855000000
Inventories
2985000000
Total Current Assets
28669000000
Property Plant Equipment
8186000000
Total Assets
99031000000
Payables
3539000000
Short Term Debt
6190000000
Long Term Debt
-
Total Liabilities
82483000000
Equity
16490000000
Depreciation
2470000000
Change In Working Capital
-1012000000
Cash From Operations
2834000000
Capital Expenditures
284000000
Cash From Investing
-19618000000
Cash From Financing
14644000000
Net Change In Cash
-2185000000
PE
0.2575
PB
6.468852268041238
ROE
-72.23165554881746
ROA
-12.02754692974927
FCF
2550000000
Fcf Percent
0.21491782553729458
Piotroski FScore
2
Health Score
28
Deep Value Investing Score
5.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
3
Momentum Investing Score
6
Net Net Investing Score
3
Quality Investing Score
3
Value Investing Score
4.5
Quarters > 0 > quarter
2024-03-31
Quarters > 0 > income Statement > revenue
11865000000
Quarters > 0 > income Statement > cost Of Revenue
2910000000
Quarters > 0 > income Statement > gross Profit
8955000000
Quarters > 0 > income Statement > operating Expenses
20226000000
Quarters > 0 > income Statement > operating Income
2284000000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-11516000000
Quarters > 0 > income Statement > net Income
-11911000000
Quarters > 0 > income Statement > eps
-5.8877904102817595
Quarters > 0 > income Statement > dividends Per Share
1212000000
Quarters > 0 > income Statement > shares Outstanding
2023000000
Quarters > 0 > income Statement > income Tax Expense
392000000
Quarters > 0 > income Statement > EBITDA
4754000000
Quarters > 0 > income Statement > operating Margin
19.249894648124737
Quarters > 0 > income Statement > total Other Income Expense Net
-13800000000
Quarters > 0 > balance Sheet > cash
9330000000
Quarters > 0 > balance Sheet > short Term Investments
340000000
Quarters > 0 > balance Sheet > receivables
10855000000
Quarters > 0 > balance Sheet > inventories
2985000000
Quarters > 0 > balance Sheet > total Current Assets
28669000000
Quarters > 0 > balance Sheet > property Plant Equipment
8186000000
Quarters > 0 > balance Sheet > total Assets
99031000000
Quarters > 0 > balance Sheet > payables
3539000000
Quarters > 0 > balance Sheet > short Term Debt
6190000000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
82483000000
Quarters > 0 > balance Sheet > equity
16490000000
Quarters > 0 > cash Flow > net Income
-11911000000
Quarters > 0 > cash Flow > depreciation
2470000000
Quarters > 0 > cash Flow > change In Working Capital
-1012000000
Quarters > 0 > cash Flow > cash From Operations
2834000000
Quarters > 0 > cash Flow > capital Expenditures
284000000
Quarters > 0 > cash Flow > cash From Investing
-19618000000
Quarters > 0 > cash Flow > cash From Financing
14644000000
Quarters > 0 > cash Flow > net Change In Cash
-2185000000
Quarters > 0 > ratios > PE
-5.8877904102817595
Quarters > 0 > ratios > PB
6.468852268041238
Quarters > 0 > ratios > ROE
-72.23165554881746
Quarters > 0 > ratios > ROA
-12.02754692974927
Quarters > 0 > ratios > FCF
2550000000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.21491782553729458
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2023-12-31
Quarters > 1 > income Statement > revenue
11477000000
Quarters > 1 > income Statement > cost Of Revenue
2707000000
Quarters > 1 > income Statement > gross Profit
8770000000
Quarters > 1 > income Statement > operating Expenses
6930000000
Quarters > 1 > income Statement > operating Income
1952000000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
1674000000
Quarters > 1 > income Statement > net Income
1762000000
Quarters > 1 > income Statement > eps
0.8666994589276931
Quarters > 1 > income Statement > dividends Per Share
1160000000
Quarters > 1 > income Statement > shares Outstanding
2033000000
Quarters > 1 > income Statement > income Tax Expense
-88000000
Quarters > 1 > income Statement > EBITDA
4373000000
Quarters > 1 > income Statement > operating Margin
17.00792890128082
Quarters > 1 > income Statement > total Other Income Expense Net
-278000000
Quarters > 1 > balance Sheet > cash
11464000000
Quarters > 1 > balance Sheet > short Term Investments
816000000
Quarters > 1 > balance Sheet > receivables
11337000000
Quarters > 1 > balance Sheet > inventories
2662000000
Quarters > 1 > balance Sheet > total Current Assets
31770000000
Quarters > 1 > balance Sheet > property Plant Equipment
8036000000
Quarters > 1 > balance Sheet > total Assets
95159000000
Quarters > 1 > balance Sheet > payables
3259000000
Quarters > 1 > balance Sheet > short Term Debt
3119000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
65674000000
Quarters > 1 > balance Sheet > equity
29430000000
Quarters > 1 > cash Flow > net Income
1762000000
Quarters > 1 > cash Flow > depreciation
2421000000
Quarters > 1 > cash Flow > change In Working Capital
-633000000
Quarters > 1 > cash Flow > cash From Operations
4252000000
Quarters > 1 > cash Flow > capital Expenditures
330000000
Quarters > 1 > cash Flow > cash From Investing
-1346000000
Quarters > 1 > cash Flow > cash From Financing
967000000
Quarters > 1 > cash Flow > net Change In Cash
3951000000
Quarters > 1 > ratios > PE
0.8666994589276931
Quarters > 1 > ratios > PB
3.6424963268773363
Quarters > 1 > ratios > ROE
5.987088005436629
Quarters > 1 > ratios > ROA
1.8516377851805925
Quarters > 1 > ratios > FCF
3922000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.3417269321251198
Quarters > 1 > health Score
57
Quarters > 2 > quarter
2023-09-30
Quarters > 2 > income Statement > revenue
10966000000
Quarters > 2 > income Statement > cost Of Revenue
2490000000
Quarters > 2 > income Statement > gross Profit
8476000000
Quarters > 2 > income Statement > operating Expenses
6166000000
Quarters > 2 > income Statement > operating Income
2104000000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
2137000000
Quarters > 2 > income Statement > net Income
1928000000
Quarters > 2 > income Statement > eps
0.9341085271317829
Quarters > 2 > income Statement > dividends Per Share
1191000000
Quarters > 2 > income Statement > shares Outstanding
2064000000
Quarters > 2 > income Statement > income Tax Expense
203000000
Quarters > 2 > income Statement > EBITDA
4555000000
Quarters > 2 > income Statement > operating Margin
19.186576691592194
Quarters > 2 > income Statement > total Other Income Expense Net
33000000
Quarters > 2 > balance Sheet > cash
7514000000
Quarters > 2 > balance Sheet > short Term Investments
171000000
Quarters > 2 > balance Sheet > receivables
10714000000
Quarters > 2 > balance Sheet > inventories
2436000000
Quarters > 2 > balance Sheet > total Current Assets
27632000000
Quarters > 2 > balance Sheet > property Plant Equipment
7848000000
Quarters > 2 > balance Sheet > total Assets
91263000000
Quarters > 2 > balance Sheet > payables
2813000000
Quarters > 2 > balance Sheet > short Term Debt
5467000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
62201000000
Quarters > 2 > balance Sheet > equity
28998000000
Quarters > 2 > cash Flow > net Income
1928000000
Quarters > 2 > cash Flow > depreciation
2451000000
Quarters > 2 > cash Flow > change In Working Capital
-503000000
Quarters > 2 > cash Flow > cash From Operations
4751000000
Quarters > 2 > cash Flow > capital Expenditures
342000000
Quarters > 2 > cash Flow > cash From Investing
-410000000
Quarters > 2 > cash Flow > cash From Financing
-5160000000
Quarters > 2 > cash Flow > net Change In Cash
-857000000
Quarters > 2 > ratios > PE
0.9341085271317829
Quarters > 2 > ratios > PB
3.753130395199669
Quarters > 2 > ratios > ROE
6.64873439547555
Quarters > 2 > ratios > ROA
2.112575742633926
Quarters > 2 > ratios > FCF
4409000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.4020609155571767
Quarters > 2 > health Score
58
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
11226000000
Quarters > 3 > income Statement > cost Of Revenue
2809000000
Quarters > 3 > income Statement > gross Profit
8417000000
Quarters > 3 > income Statement > operating Expenses
6380000000
Quarters > 3 > income Statement > operating Income
1994000000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
1859000000
Quarters > 3 > income Statement > net Income
2073000000
Quarters > 3 > income Statement > eps
0.9862036156041865
Quarters > 3 > income Statement > dividends Per Share
1197000000
Quarters > 3 > income Statement > shares Outstanding
2102000000
Quarters > 3 > income Statement > income Tax Expense
-218000000
Quarters > 3 > income Statement > EBITDA
4445000000
Quarters > 3 > income Statement > operating Margin
17.762337430963836
Quarters > 3 > income Statement > total Other Income Expense Net
-135000000
Quarters > 3 > balance Sheet > cash
8372000000
Quarters > 3 > balance Sheet > short Term Investments
358000000
Quarters > 3 > balance Sheet > receivables
10517000000
Quarters > 3 > balance Sheet > inventories
2364000000
Quarters > 3 > balance Sheet > total Current Assets
28074000000
Quarters > 3 > balance Sheet > property Plant Equipment
7629000000
Quarters > 3 > balance Sheet > total Assets
93489000000
Quarters > 3 > balance Sheet > payables
3069000000
Quarters > 3 > balance Sheet > short Term Debt
3020000000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
61459000000
Quarters > 3 > balance Sheet > equity
31973000000
Quarters > 3 > cash Flow > net Income
2073000000
Quarters > 3 > cash Flow > depreciation
2451000000
Quarters > 3 > cash Flow > change In Working Capital
-81000000
Quarters > 3 > cash Flow > cash From Operations
1887000000
Quarters > 3 > cash Flow > capital Expenditures
259000000
Quarters > 3 > cash Flow > cash From Investing
-329000000
Quarters > 3 > cash Flow > cash From Financing
-2173000000
Quarters > 3 > cash Flow > net Change In Cash
-623000000
Quarters > 3 > ratios > PE
0.9862036156041865
Quarters > 3 > ratios > PB
3.466580821317987
Quarters > 3 > ratios > ROE
6.483595533731585
Quarters > 3 > ratios > ROA
2.2173731668966403
Quarters > 3 > ratios > FCF
1628000000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.14502048815250312
Quarters > 3 > health Score
55
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
45006000000
Annuals > 0 > income Statement > cost Of Revenue
10518000000
Annuals > 0 > income Statement > gross Profit
34488000000
Annuals > 0 > income Statement > operating Expenses
25336000000
Annuals > 0 > income Statement > operating Income
8651000000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
8440000000
Annuals > 0 > income Statement > net Income
8025000000
Annuals > 0 > income Statement > eps
3.861886429258903
Annuals > 0 > income Statement > dividends Per Share
4744000000
Annuals > 0 > income Statement > shares Outstanding
2078000000
Annuals > 0 > income Statement > income Tax Expense
400000000
Annuals > 0 > income Statement > EBITDA
18420000000
Annuals > 0 > income Statement > operating Margin
19.221881526907524
Annuals > 0 > income Statement > total Other Income Expense Net
-211000000
Annuals > 0 > balance Sheet > cash
11464000000
Annuals > 0 > balance Sheet > short Term Investments
816000000
Annuals > 0 > balance Sheet > receivables
11337000000
Annuals > 0 > balance Sheet > inventories
2662000000
Annuals > 0 > balance Sheet > total Current Assets
31770000000
Annuals > 0 > balance Sheet > property Plant Equipment
8036000000
Annuals > 0 > balance Sheet > total Assets
95159000000
Annuals > 0 > balance Sheet > payables
3259000000
Annuals > 0 > balance Sheet > short Term Debt
3119000000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
65674000000
Annuals > 0 > balance Sheet > equity
29430000000
Annuals > 0 > cash Flow > net Income
8025000000
Annuals > 0 > cash Flow > depreciation
9769000000
Annuals > 0 > cash Flow > change In Working Capital
-1509000000
Annuals > 0 > cash Flow > cash From Operations
13860000000
Annuals > 0 > cash Flow > capital Expenditures
1209000000
Annuals > 0 > cash Flow > cash From Investing
-2295000000
Annuals > 0 > cash Flow > cash From Financing
-9416000000
Annuals > 0 > cash Flow > net Change In Cash
2194000000
Annuals > 0 > ratios > PE
3.861886429258903
Annuals > 0 > ratios > PB
3.669128059802922
Annuals > 0 > ratios > ROE
27.268093781855253
Annuals > 0 > ratios > ROA
8.433253817295263
Annuals > 0 > ratios > FCF
12651000000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.2810958538861485
Annuals > 0 > health Score
73
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
46159000000
Annuals > 1 > income Statement > cost Of Revenue
9781000000
Annuals > 1 > income Statement > gross Profit
36378000000
Annuals > 1 > income Statement > operating Expenses
27631000000
Annuals > 1 > income Statement > operating Income
9879000000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
7713000000
Annuals > 1 > income Statement > net Income
6327000000
Annuals > 1 > income Statement > eps
2.9482758620689653
Annuals > 1 > income Statement > dividends Per Share
4634000000
Annuals > 1 > income Statement > shares Outstanding
2146000000
Annuals > 1 > income Statement > income Tax Expense
1368000000
Annuals > 1 > income Statement > EBITDA
20161000000
Annuals > 1 > income Statement > operating Margin
21.402110097705755
Annuals > 1 > income Statement > total Other Income Expense Net
-2166000000
Annuals > 1 > balance Sheet > cash
9123000000
Annuals > 1 > balance Sheet > short Term Investments
130000000
Annuals > 1 > balance Sheet > receivables
10390000000
Annuals > 1 > balance Sheet > inventories
2339000000
Annuals > 1 > balance Sheet > total Current Assets
27273000000
Annuals > 1 > balance Sheet > property Plant Equipment
7475000000
Annuals > 1 > balance Sheet > total Assets
96820000000
Annuals > 1 > balance Sheet > payables
3040000000
Annuals > 1 > balance Sheet > short Term Debt
4264000000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
65702000000
Annuals > 1 > balance Sheet > equity
31061000000
Annuals > 1 > cash Flow > net Income
6327000000
Annuals > 1 > cash Flow > depreciation
10282000000
Annuals > 1 > cash Flow > change In Working Capital
-732000000
Annuals > 1 > cash Flow > cash From Operations
13066000000
Annuals > 1 > cash Flow > capital Expenditures
1118000000
Annuals > 1 > cash Flow > cash From Investing
-1062000000
Annuals > 1 > cash Flow > cash From Financing
-16962000000
Annuals > 1 > cash Flow > net Change In Cash
-4991000000
Annuals > 1 > ratios > PE
2.9482758620689653
Annuals > 1 > ratios > PB
3.590226702295483
Annuals > 1 > ratios > ROE
20.369595312449697
Annuals > 1 > ratios > ROA
6.5348068580871725
Annuals > 1 > ratios > FCF
11948000000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.2588444290387573
Annuals > 1 > health Score
71
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
46385000000
Annuals > 2 > income Statement > cost Of Revenue
9940000000
Annuals > 2 > income Statement > gross Profit
36445000000
Annuals > 2 > income Statement > operating Expenses
27083000000
Annuals > 2 > income Statement > operating Income
8572000000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
8098000000
Annuals > 2 > income Statement > net Income
6994000000
Annuals > 2 > income Statement > eps
3.1153674832962137
Annuals > 2 > income Statement > dividends Per Share
4396000000
Annuals > 2 > income Statement > shares Outstanding
2245000000
Annuals > 2 > income Statement > income Tax Expense
1084000000
Annuals > 2 > income Statement > EBITDA
19329000000
Annuals > 2 > income Statement > operating Margin
18.480112105206427
Annuals > 2 > income Statement > total Other Income Expense Net
-474000000
Annuals > 2 > balance Sheet > cash
13979000000
Annuals > 2 > balance Sheet > short Term Investments
3242000000
Annuals > 2 > balance Sheet > receivables
9730000000
Annuals > 2 > balance Sheet > inventories
2095000000
Annuals > 2 > balance Sheet > total Current Assets
33262000000
Annuals > 2 > balance Sheet > property Plant Equipment
6968000000
Annuals > 2 > balance Sheet > total Assets
109314000000
Annuals > 2 > balance Sheet > payables
2949000000
Annuals > 2 > balance Sheet > short Term Debt
4948000000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
73308000000
Annuals > 2 > balance Sheet > equity
35946000000
Annuals > 2 > cash Flow > net Income
6994000000
Annuals > 2 > cash Flow > depreciation
10757000000
Annuals > 2 > cash Flow > change In Working Capital
-1041000000
Annuals > 2 > cash Flow > cash From Operations
16207000000
Annuals > 2 > cash Flow > capital Expenditures
973000000
Annuals > 2 > cash Flow > cash From Investing
-538000000
Annuals > 2 > cash Flow > cash From Financing
-16224000000
Annuals > 2 > cash Flow > net Change In Cash
-657000000
Annuals > 2 > ratios > PE
3.1153674832962137
Annuals > 2 > ratios > PB
3.245438351972403
Annuals > 2 > ratios > ROE
19.456963222611694
Annuals > 2 > ratios > ROA
6.398082587774667
Annuals > 2 > ratios > FCF
15234000000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.32842513743667134
Annuals > 2 > health Score
70
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
42518000000
Annuals > 3 > income Statement > cost Of Revenue
11773000000
Annuals > 3 > income Statement > gross Profit
30745000000
Annuals > 3 > income Statement > operating Expenses
36356000000
Annuals > 3 > income Statement > operating Income
3391000000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-6871000000
Annuals > 3 > income Statement > net Income
-9015000000
Annuals > 3 > income Statement > eps
-3.992471213463242
Annuals > 3 > income Statement > dividends Per Share
4075000000
Annuals > 3 > income Statement > shares Outstanding
2258000000
Annuals > 3 > income Statement > income Tax Expense
2124000000
Annuals > 3 > income Statement > EBITDA
13824000000
Annuals > 3 > income Statement > operating Margin
7.975445693588598
Annuals > 3 > income Statement > total Other Income Expense Net
-10262000000
Annuals > 3 > balance Sheet > cash
14546000000
Annuals > 3 > balance Sheet > short Term Investments
1904000000
Annuals > 3 > balance Sheet > receivables
8755000000
Annuals > 3 > balance Sheet > inventories
2074000000
Annuals > 3 > balance Sheet > total Current Assets
30192000000
Annuals > 3 > balance Sheet > property Plant Equipment
6745000000
Annuals > 3 > balance Sheet > total Assets
118481000000
Annuals > 3 > balance Sheet > payables
2713000000
Annuals > 3 > balance Sheet > short Term Debt
2340000000
Annuals > 3 > balance Sheet > long Term Debt
48336000000
Annuals > 3 > balance Sheet > total Liabilities
80599000000
Annuals > 3 > balance Sheet > equity
37822000000
Annuals > 3 > cash Flow > net Income
-9015000000
Annuals > 3 > cash Flow > depreciation
10433000000
Annuals > 3 > cash Flow > change In Working Capital
2026000000
Annuals > 3 > cash Flow > cash From Operations
14052000000
Annuals > 3 > cash Flow > capital Expenditures
753000000
Annuals > 3 > cash Flow > cash From Investing
-10859000000
Annuals > 3 > cash Flow > cash From Financing
-1151000000
Annuals > 3 > cash Flow > net Change In Cash
2153000000
Annuals > 3 > ratios > PE
-3.992471213463242
Annuals > 3 > ratios > PB
3.1023231664110833
Annuals > 3 > ratios > ROE
-23.8353339326318
Annuals > 3 > ratios > ROA
-7.608814915471679
Annuals > 3 > ratios > FCF
13299000000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.3127851733383508
Annuals > 3 > health Score
35
Valuation > metrics > PE
0.2575
Valuation > metrics > PB
6.468852268041238
Valuation > final Score
40
Valuation > verdict
9.1% Overvalued
Profitability > metrics > ROE
-72.23165554881746
Profitability > metrics > ROA
-41.54661829851059
Profitability > metrics > Net Margin
-1.0038769490096924
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
5.0020012128562765
Risk > metrics > Interest Coverage
0.14038106945298096
Risk > final Score
7
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.946757117894953
Liquidity > metrics > Quick Ratio
2.639942440127454
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
63.57503673122664
Prev Valuations > 1
62.46869604800331
Prev Valuations > 2
65.33419178682013
Prev Profitabilities > 0
52
Prev Profitabilities > 1
61
Prev Profitabilities > 2
63
Prev Risks > 0
21
Prev Risks > 1
21
Prev Risks > 2
33
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:58:18.120Z
Earnings History > 0 > period
2026-09-30
Earnings History > 0 > report Date
2026-10-29
Earnings History > 0 > date
2026-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2026-06-30
Earnings History > 1 > report Date
2026-07-30
Earnings History > 1 > date
2026-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2026-03-31
Earnings History > 2 > report Date
2026-04-30
Earnings History > 2 > date
2026-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-12-31
Earnings History > 3 > report Date
2026-02-05
Earnings History > 3 > date
2025-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-
Earnings History > 3 > eps Estimate
1.65
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2025-09-30
Earnings History > 4 > report Date
2025-10-30
Earnings History > 4 > date
2025-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
1.0795
Earnings History > 4 > eps Estimate
1.52
Earnings History > 4 > eps Difference
-0.4405
Earnings History > 4 > surprise Percent
-28.9803
Earnings History > 5 > period
2025-06-30
Earnings History > 5 > report Date
2025-07-31
Earnings History > 5 > date
2025-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.6428
Earnings History > 5 > eps Estimate
1.13
Earnings History > 5 > eps Difference
-0.4872
Earnings History > 5 > surprise Percent
-43.115
Earnings History > 6 > period
2025-03-31
Earnings History > 6 > report Date
2025-04-24
Earnings History > 6 > date
2025-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
1.2039
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-12-31
Earnings History > 7 > report Date
2025-02-06
Earnings History > 7 > date
2024-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.0353
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-09-30
Earnings History > 8 > report Date
2024-10-31
Earnings History > 8 > date
2024-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.5963
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2024-06-30
Earnings History > 9 > report Date
2024-07-26
Earnings History > 9 > date
2024-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0.828
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2024-03-31
Earnings History > 10 > report Date
2024-04-25
Earnings History > 10 > date
2024-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-5.8878
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-12-31
Earnings History > 11 > report Date
2024-03-14
Earnings History > 11 > date
2023-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0.8667
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-09-30
Earnings History > 12 > report Date
2023-10-26
Earnings History > 12 > date
2023-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
0.9341
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2023-06-30
Earnings History > 13 > report Date
2023-07-27
Earnings History > 13 > date
2023-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
0.9862
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2023-03-31
Earnings History > 14 > report Date
2023-04-27
Earnings History > 14 > date
2023-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
1.0705
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-12-31
Earnings History > 15 > report Date
2023-03-20
Earnings History > 15 > date
2022-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
0.952
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-09-30
Earnings History > 16 > report Date
2022-10-26
Earnings History > 16 > date
2022-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
0.7477
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2022-06-30
Earnings History > 17 > report Date
2022-07-27
Earnings History > 17 > date
2022-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
0.6612
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2022-03-31
Earnings History > 18 > report Date
2022-04-29
Earnings History > 18 > date
2022-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
0.5906
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-12-31
Earnings History > 19 > report Date
2022-02-04
Earnings History > 19 > date
2021-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
1.069
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-09-30
Earnings History > 20 > report Date
2021-10-27
Earnings History > 20 > date
2021-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
0.6893
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2021-06-30
Earnings History > 21 > report Date
2021-07-28
Earnings History > 21 > date
2021-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
0.4685
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2021-03-31
Earnings History > 22 > report Date
2021-04-29
Earnings History > 22 > date
2021-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
0.8923
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-12-31
Earnings History > 23 > report Date
2020-12-31
Earnings History > 23 > date
2020-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-4.4525
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-09-30
Earnings History > 24 > report Date
2020-09-30
Earnings History > 24 > date
2020-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
0.8175
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2020-06-30
Earnings History > 25 > report Date
2020-06-30
Earnings History > 25 > date
2020-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.0376
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2020-03-31
Earnings History > 26 > report Date
2020-03-31
Earnings History > 26 > date
2020-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.3432
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-12-31
Earnings History > 27 > report Date
2019-12-31
Earnings History > 27 > date
2019-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-0.5506
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2019-09-30
Earnings History > 28 > report Date
2019-09-30
Earnings History > 28 > date
2019-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
0.828
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2019-06-30
Earnings History > 29 > report Date
2019-06-30
Earnings History > 29 > date
2019-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
0.8748
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2019-03-31
Earnings History > 30 > report Date
2019-03-31
Earnings History > 30 > date
2019-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
1.0446
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-12-31
Earnings History > 31 > report Date
2018-12-31
Earnings History > 31 > date
2018-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
0.7282
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2018-09-30
Earnings History > 32 > report Date
2018-09-30
Earnings History > 32 > date
2018-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
1.162
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2018-06-30
Earnings History > 33 > report Date
2018-06-30
Earnings History > 33 > date
2018-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
-
Earnings History > 33 > eps Actual
0.228
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2018-03-31
Earnings History > 34 > report Date
2018-03-31
Earnings History > 34 > date
2018-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
-
Earnings History > 34 > eps Actual
0.9061
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-12-31
Earnings History > 35 > report Date
2017-12-31
Earnings History > 35 > date
2017-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
-
Earnings History > 35 > eps Actual
-1.4239
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2017-09-30
Earnings History > 36 > report Date
2017-09-30
Earnings History > 36 > date
2017-09-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
-
Earnings History > 36 > eps Actual
0.5137
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2017-06-30
Earnings History > 37 > report Date
2017-06-30
Earnings History > 37 > date
2017-06-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
-
Earnings History > 37 > eps Actual
0.5552
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2017-03-31
Earnings History > 38 > report Date
2017-03-31
Earnings History > 38 > date
2017-03-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
-
Earnings History > 38 > eps Actual
0.942
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-12-31
Earnings History > 39 > report Date
2016-12-31
Earnings History > 39 > date
2016-12-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
-
Earnings History > 39 > eps Actual
0.5321
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2016-09-30
Earnings History > 40 > report Date
2016-09-30
Earnings History > 40 > date
2016-09-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
-
Earnings History > 40 > eps Actual
0.7159
Earnings History > 40 > eps Estimate
-
Earnings History > 40 > eps Difference
0
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2016-06-30
Earnings History > 41 > report Date
2016-06-30
Earnings History > 41 > date
2016-06-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
-
Earnings History > 41 > eps Actual
0.6945
Earnings History > 41 > eps Estimate
-
Earnings History > 41 > eps Difference
0
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2016-03-31
Earnings History > 42 > report Date
2016-03-31
Earnings History > 42 > date
2016-03-31
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
-
Earnings History > 42 > eps Actual
0.7113
Earnings History > 42 > eps Estimate
-
Earnings History > 42 > eps Difference
0
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2015-12-31
Earnings History > 43 > report Date
2015-12-31
Earnings History > 43 > date
2015-12-31
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
-
Earnings History > 43 > eps Actual
-0.0827
Earnings History > 43 > eps Estimate
-
Earnings History > 43 > eps Difference
0
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2015-09-30
Earnings History > 44 > report Date
2015-09-30
Earnings History > 44 > date
2015-09-30
Earnings History > 44 > before After Market
-
Earnings History > 44 > currency
-
Earnings History > 44 > eps Actual
0.4207
Earnings History > 44 > eps Estimate
-
Earnings History > 44 > eps Difference
0
Earnings History > 44 > surprise Percent
-
Earnings History > 45 > period
2015-06-30
Earnings History > 45 > report Date
2015-06-30
Earnings History > 45 > date
2015-06-30
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
-
Earnings History > 45 > eps Actual
-0.078
Earnings History > 45 > eps Estimate
-
Earnings History > 45 > eps Difference
0
Earnings History > 45 > surprise Percent
-
Earnings History > 46 > period
2015-03-31
Earnings History > 46 > report Date
2015-03-31
Earnings History > 46 > date
2015-03-31
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
-
Earnings History > 46 > eps Actual
0.7076
Earnings History > 46 > eps Estimate
-
Earnings History > 46 > eps Difference
0
Earnings History > 46 > surprise Percent
-
Earnings History > 47 > period
2014-12-31
Earnings History > 47 > report Date
2014-12-31
Earnings History > 47 > date
2014-12-31
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
-
Earnings History > 47 > eps Actual
0.0078
Earnings History > 47 > eps Estimate
-
Earnings History > 47 > eps Difference
0
Earnings History > 47 > surprise Percent
-
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-03-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Bristol Myers Squibb Co.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
1.65
Date
2025-09-30
EPS Actual
1.0795
EPS Estimate
1.52
EPS Difference
-0.4405
Surprise Percent
-28.9803%
(Last Updated 2024-03-31)
(Last Updated 2024-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.